[Opportunistic diseases in HIV infection]

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Opportunistic diseases significantly contribute to HIV-associated morbidity and mortality.
• Patients with undiagnosed HIV often present with opportunistic infections, necessitating clinical awareness.
• Severe immunodeficiency, indicated by low CD4 counts, requires primary prophylaxis against specific infections.

Purpose of the Study:

• To review the clinical presentations and management of opportunistic diseases in HIV patients.
• To evaluate the impact of antiretroviral therapy on opportunistic infections and prophylaxis.
• To discuss immune reconstitution inflammatory syndromes (IRIS) in the context of improving immunocompetence.

Main Methods:

• Analysis of data from the multicenter Swiss HIV Cohort Study.
• Documentation of opportunistic diseases and their management.
• Review of clinical presentations and treatment outcomes.

Main Results:

• Potent antiretroviral combination therapy has reduced the incidence and mortality of most opportunistic diseases.
• Antiretroviral therapy allows for the discontinuation of primary prophylaxis and maintenance therapy if CD4 counts durably increase.
• Improved immunocompetence due to antiretroviral therapy is linked to immune reconstitution inflammatory syndromes.

Conclusions:

• Clinicians must be aware of opportunistic infection presentations in HIV patients.
• Antiretroviral therapy has transformed the management of HIV-related opportunistic diseases.
• Further research and cohort studies are crucial for optimizing HIV patient care.